Brief: Bolt Biotherapeutics Reports Third Quarter 2022 Financial Results And Provides Business Update
10/11/2022 22:03
Nov 10 (Reuters) - Bolt Biotherapeutics Inc BOLT.O :
* BOLT BIOTHERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATE
* QTRLY LOSS PER SHARE $0.58
* Q3 EARNINGS PER SHARE VIEW $-0.56 -- REFINITIV IBES DATA
* QTRLY COLLABORATION REVENUE WAS $2.1 MILLION FOR Q3 ENDED
SEPTEMBER 30, 2022, COMPARED TO $0.8 MILLION
* Q3 REVENUE VIEW $984600.00 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX5DnsdW
Further company coverage: BOLT.O
((Reuters.Briefs@thomsonreuters.com;;))